The gastric acid suppression medications studied in the Mayo Clinic research included proton pump inhibitors such as omeprazole and histamine 2 blockers such as ranitidine.
Notes on verification
Confirmed by multiple independent sources reporting on the same 2017 JAMA Internal Medicine study, including press coverage quoting the senior author and the peer-reviewed article itself. [cascade flags: aggregator_dropped_primary_exists | tier=silver indep_score=0.89 clusters=5 claim_tier=notable]
Sources
- Gastric acid suppression medications increase risk for recurrence of ... (seed:health_and_medicine)
- https://pubmed.ncbi.nlm.nih.gov/28346595/ (corroboration)
- https://www.uspharmacist.com/article/gastric-acid-suppression-medications-raise-recurrent-c-difficile-infection-risk (corroboration)
- https://www.ajmc.com/view/researchers-identify-link-between-gastric-acid-suppressants-and-recurrent-c-diff-infection (corroboration)
- https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2612117 (corroboration)
- https://medicalxpress.com/news/2017-03-gastric-medications-recurrence-clostridium-difficile.html (corroboration)